Guido Ferrari
Professor in Surgery
Research Professor in Molecular Genetics and Microbiology
Affiliate, Duke Global Health Institute
Dr. Ferrari is currently aProfessor in the Department of Surgery, Division of Surgical Sciences at Duke University Medical Center. He is directing the CFAR Immunology Core and ADCC laboratories for the HVTN, CAVD, and PAVEG central laboratory at Duke. He served as a WHO/UNAIDS Vaccine Initiative consultant for six years, and coordinated the organization of 5 international workshops for the transfer of ELISpot and ICS technologies to new laboratory sites involved in HIV vaccine studies. He is involved in several initiative supported by NIH and IAS to mentor young investigators in limited resources countries to fight infectious diseases that include AIDS, tuberculosis, and malaria.
Projects
Publications
-
Montefiori DC, Ferrari G, Mielke D, Williams LD, Tomaras GD. Current Approaches for Assessments of Neutralizing, Binding, and Effector Functions of Antibodies on the Path to Antibody-Mediated Prevention Strategies for HIV-1. Curr HIV Res. 2025 Mar 27;Mitchell JL, Buranapraditkun S, Gantner P, Takata H, Dietze K, N’guessan KF, et al. Activation of CXCR3+ Tfh cells and B cells in lymph nodes during acute HIV-1 infection correlates with HIV-specific antibody development. J Virol. 2025 Mar 18;99(3):e0153224.Mielke D, Tuyishime M, Kelkar NS, Wang Y, Parks R, Santra S, et al. Computationally Selected Multivalent HIV-1 Subtype C Vaccine Protects Against Heterologous SHIV Challenge. Vaccines. 2025 Mar 1;13(3).McKellar MS, Keys JR, Filiatreau LM, McGee KS, Kuruc JD, Ferrari G, et al. Rapid viral suppression using integrase inhibitors during acute HIV-1 infection. J Antimicrob Chemother. 2025 Jan 3;80(1):169–74.
See more publications at Scholars@Duke